维普中文期刊产品整合服务
51篇 您的检索式:作者名="Bomalaski"
    题名 作者 年代 出处 被引量
1Pegylated Arginine Deiminase (ADI-SS PEG20,O00 row)Inhibits Human Melanomasand Hepatocellular Carcinomasin Vitro and in Vivo显示文摘ENSOR CM HOLTSBERG FW BOMALASKI JS 2002Cancer research2002,62,:1
2Pegylated arginine deiminase (ADI-SS PEG20, 000mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo显示文摘ENSOR C M HOLTSBERG F W BOMALASKI J S 2002Cancer Res2002,62,19:1
3Pegylated arginine deminase (ADI-SS PEG20,000mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo 显示文摘Ensor CM Holtsberg FW Bomalaski JS 2002Cancer Res2002,62,19:1
4Uricase formulated with polyethylene glycol(Uricase-PEG 20):biochemical rationale and preclinical studies显示文摘Bomalaski JS Holtsberg FW Ensor CM 2002J Rheumatol2002,29,9:1
5Diagnosis and manage- ment of vulvar and vaginal intraepithelial neoplasia显示文摘Cardosi R J Bomalaski J J Hoffman M S 2001Obstet Gy- necol Clin North Am2001,28,4:1
6Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors 显示文摘TOMLINSON B K THOMSON J A BOMALASKI J S 2015Clinical Cancer Research2015,21,11:1
7Serum uric acid-lowering therapies:where are we heading in management of hyperuricemia and the potential role of uricase显示文摘Bomalaski JS Clark MA 0,,03:1
8Pegylated arginine deiminase ( ADI-SS PEG20,000 mw ) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo显示文摘Ensor C M Hohsberg F W Bomalaski J S 2002Cancer Res2002,62,19:1
9Serum uric acid lowering the rapies: where are we heading in management of hyperuricemia and the potential role of uricase 显示文摘Bomalaski JS Clark MA 2004Curr Rheumatol Rep2004,6,3:1
10Diagnosis and management of vulvar and vaginal intraepithelial neoplasia显示文摘Cardosi RJ Bomalaski JJ Hoffman MS 2001Obstet Gynecol Clin North Am2001,28,4:1
11Serum uric acid-lowing therapies,where are we heading in management of hyperuricemia and the potential role of uricase 显示文摘Bomalaski JS Clark MA 2004Curr Rheumatol Rep2004,6,3:1
12Uricase formulated with polyethylene glycol ( uficase-peg 20) : Bio-chemical rationale and preclinical studies 显示文摘BOMALASKI J S HOLTSBERG F W ENSOR C M 2002J Rheumatol2002,29,9:1
13Serum uric acid-lowering therapies: Where are we heading in management of hyperuricemia and the potential role of uricase显示文摘Bomalaski JS Clark MA 2004Curt Rheumatol Rep2004,6,3:1
14Diagnosis and management of vulvar and vaginal intraepithelial neoplasia显示文摘Cardosi RJ Bomalaski JJ Hoffman MS 2001Obstet Gynecol Clin North Am2001,28,4:1
15Serum uric acid-lowering therapies:whereare we leading in management of hyperuricemia and the potential roleof uricase显示文摘Bomalaski JS Clark MA 2004Curr Rheumatol Rep2004,6,3:1
16Pegylated arginine deiminase (ADI-SS-PEG20,000 mw)inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo显示文摘Ensor C M Holtsberg F W Bomalaski J S 2002Cancer Research2002,62,19:1
17A lightweight ambient air-cooling unit for use in hazardous environments 显示文摘CHEN YT constable SH Bomalaski SH 1997Am Ind Hygiene Assoc J1997,58,1:1
18Concomitant activation of extracellular signal-regulated kinase and induction of COX-2 stimulates maximum prostaglandin E2 synthesis in human airway epithelial cells显示文摘PETROVIC N KNIGHT D A BOMALASKI J S 2006Prostaglandins Other Lipid Mediat2006,81,:1
19Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma显示文摘Patrick A. Ott Richard D. Carvajal Neeta Pandit-Taskar Achim A. Jungbluth Eric W. Hoffman Bor-Wen Wu John S. Bomalaski Ralph Venhaus Linda Pan Lloyd J. Old Anna C. Pavlick Jedd D. Wolchok 2013Investigational New Drugs2013,,2:1
20Formulation of arginine deiminase with polyethylene glycol(peg):effects of different linkers and molecular weight of PKG on the pharmacokinetics,pharma-codynamics and immunogenicity of this enzyme显示文摘Holtsberg FW Ensor CM Bomalaski JS 2002J Controlled Release2002,2380,13:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费